- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02513407
Eat, Move, Live Intervention in Reducing Chronic Disease Risk in Medically Vulnerable Communities
Reducing Cancer and Chronic Disease Risk in Medically Vulnerable Communities: A Feasibility Study Measuring Behavioral and Biological Outcomes of the Eat Move Live Intervention
Study Overview
Status
Conditions
Detailed Description
PRIMARY OBJECTIVES:
I. Level of exercise.
II. Reduction in barriers to exercise.
III. Level of self-reported 5-9 servings of fruits and vegetables consumption.
IV. Reduction in barriers to fruit and vegetable consumption.
V. Improvement in biologic/metabolic markers such as hemoglobin A1c, fasting plasma glucose, and body weight.
OUTLINE: Participants are randomized to 1 of 2 groups.
GROUP I: Participants complete an assessment on knowledge, attitudes, and behaviors at baseline and attend 2 weekday sessions comprised of interactive education segment that is culturally responsive, and based on the community EML program, and topics including: nutrition guideline, nutrition label reading, comparison shopping/grocery store tour, recipe modification and healthy food preparation, eating healthy on a budget, and making healthy choices outside the home (e.g., restaurants) and physical activity over 1 hour led by Certified Health Educator (CHE), a physical activity conducted by Duarte Fitness Centers instructors over 30 minutes, and cooking/taste test demonstration co-led by the CHE and local chef over 30 minutes over 12 weeks. Participants are also prescribed and encouraged to participate in 3 days a week exercise classes (for > 30 minutes) including salsa, Zumba and other aerobic exercises that are provided at Duarte Fitness Center.
GROUP II: Participants receive a fitness tracker to track their physical activity and be wait listed to receive the intervention during month 10-12.
After completion of study, participants are followed up immediately and at 3 months.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
California
-
Duarte, California, United States, 91010
- City of Hope Medical Center
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Mothers/female guardians of elementary aged students
- Self identify as Latina
- Not adherent to the standard for > five servings of fruits and vegetable and 150 minutes of physical activity
Exclusion Criteria:
- Not a parent of elementary aged student in Duarte Unified School District (DUSD)
- Does not self-identify as Latina
- Does not speak/read/write/understand English/Spanish - Diagnosed with diabetes
- Consumes 5+ servings of fruits and vegetables and is active for at least 30 minutes 5+ days per week
- Has a condition or psychological difficulties that affects day-to-day activities
- Has physical limitations and cannot participate in physical activity
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Group I (EML)
Participants complete an assessment on knowledge, attitudes, and behaviors at baseline and attend 2 weekday sessions comprised of interactive education segment that is culturally responsive, and based on the community EML program, and topics including: nutrition guideline, nutrition label reading, comparison shopping/grocery store tour, recipe modification and healthy food preparation, eating healthy on a budget, and making healthy choices outside the home (e.g., restaurants) and physical activity over 1 hour led by CHE, a physical activity conducted by Duarte Fitness Centers instructors over 30 minutes, and cooking/taste test demonstration co-led by the CHE and local chef over 30 minutes over 12 weeks.
Participants are also prescribed and encouraged to participate in 3 days a week exercise classes (for > 30 minutes) including salsa, Zumba and other aerobic exercises that are provided at Duarte Fitness Center.
|
Correlative studies
Ancillary studies
Attend healthy nutritional education session
Attend EML educational session
Other Names:
Attend exercise educational session
Receive fitness tracker
|
|
Active Comparator: Group II (control)
Participants receive a fitness tracker to track their physical activity and be wait listed to receive the intervention during month 10-12.
|
Correlative studies
Ancillary studies
Attend healthy nutritional education session
Attend exercise educational session
Receive fitness tracker
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Changes in plasma glucose level measured using point of care glucometer OneTouch Ultra® 2
Time Frame: Baseline to up to 3 months
|
Will convert plasma glucose into binary outcome variables and evaluate the effect on intervention on these outcomes controlled for significant confounders (age, income, and education will be evaluated for confounding in the logistic regression model).
Chi-square goodness of fit tests will compare percent reduction in weight between the control and intervention groups.
Chi square tests will be used to determine whether participants reduced weight by 3%.
Repeated ANCOVA will be used.
Outcome variables will be dichotomized to fit a logistic regression modeling procedures.
|
Baseline to up to 3 months
|
|
Changes in hemoglobin A1c level measured using a point of care device A1CNow®
Time Frame: Baseline to up to 3 months
|
Will convert hemoglobin A1c into binary outcome variables and evaluate the effect on intervention on these outcomes controlled for significant confounders (age, income, and education will be evaluated for confounding in the logistic regression model).
Chi-square goodness of fit tests will compare percent reduction in weight between the control and intervention groups.
Chi square tests will be used to determine whether participants reduced weight by 3%.
Repeated ANCOVA will be used.
Outcome variables will be dichotomized to fit a logistic regression modeling procedures.
|
Baseline to up to 3 months
|
|
Changes in level of self reported 5-9 servings of fruits and vegetables using self evaluation and the daily food diary
Time Frame: Baseline to up to 3 months
|
Chi-square test and Logistic regression analysis will be used to determine whether the intervention significantly motivated participants to consume 7-8 servings of fruits/vegetables per day, adjusting for significant confounders (e.g., age, baseline BMI).
Additionally, the Cochran Q test will be used to evaluate changes on barriers to fruit/vegetable consumption at the baseline and follow-up time points.
|
Baseline to up to 3 months
|
|
Changes in reduction in barriers to exercise using self-report evaluation based on historical EML program using Likert-type scale items
Time Frame: Baseline to up to 3 months
|
Compliance to exercise at baseline and follow-up will be assessed using Logistic regression analysis.
Additionally, the Cochran Q test will be used to evaluate changes on barriers to exercise at the baseline and follow-up time points.
|
Baseline to up to 3 months
|
|
Changes in self-reports of activity tracker readings
Time Frame: Up to 3 months
|
Will compare baseline and follow-up exercise levels between the intervention and control groups in an independent t-tests, and compare the pre- to post-intervention change in activity tracker readings between groups with repeated measure analysis of covariance with age and baseline body mass index (BMI) as confounders.
|
Up to 3 months
|
|
Reduction in barriers to fruit and vegetable consumption using self-evaluation based on historical EML program using Likert-type scale
Time Frame: Baseline to up to 3 months
|
Cochran Q test will be used to assess participants' barriers to fruit and vegetable consumption at different follow up period.
|
Baseline to up to 3 months
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Kimlin Ashing-Giwa, City of Hope Medical Center
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimated)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 15160 (Other Identifier: City of Hope Medical Center)
- NCI-2015-01220 (Registry Identifier: CTRP (Clinical Trial Reporting Program))
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Healthy Subject
-
Ohio State University Comprehensive Cancer CenterNational Cancer Institute (NCI)Completed
-
Changchun GeneScience Pharmaceutical Co., Ltd.Completed
-
CelltrionCompletedHealthy SubjectKorea, Republic of
-
Staidson (Beijing) Biopharmaceuticals Co., LtdCompleted
-
GeneScience Pharmaceuticals Co., Ltd.Completed
-
Kyowa Kirin Co., Ltd.Completed
-
Jun ZhuNanjing Legend Biotech Co.Recruiting
-
Staidson (Beijing) Biopharmaceuticals Co., LtdTerminated
-
Daewoong Pharmaceutical Co. LTD.CompletedHealthy SubjectKorea, Democratic People's Republic of
-
Beijing InnoCare Pharma Tech Co., Ltd.Active, not recruitingHealthy SubjectChina
Clinical Trials on Laboratory Biomarker Analysis
-
China National Center for Cardiovascular DiseasesPeking Union Medical College HospitalRecruiting
-
Barbara Ann Karmanos Cancer InstituteNational Cancer Institute (NCI)CompletedPancreatic CancerUnited States
-
Children's Oncology GroupNational Cancer Institute (NCI)Completed
-
Consorci Sanitari de l'Alt Penedès i GarrafRecruiting
-
Centre Oscar LambretCompleted
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedSecondary Acute Myeloid Leukemia | Childhood Acute Myeloid Leukemia in Remission | Childhood Acute Lymphoblastic Leukemia in Remission | Recurrent Childhood Acute Lymphoblastic Leukemia | Recurrent Childhood Acute Myeloid Leukemia | Adult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11 and other conditionsUnited States
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)WithdrawnLung CancerUnited States
-
Children's Oncology GroupNational Cancer Institute (NCI)WithdrawnChildhood Atypical Teratoid/Rhabdoid Tumor | Rhabdoid Tumor of the KidneyUnited States
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)CompletedRecurrent Uterine Corpus Carcinoma | Stage I Uterine Corpus Cancer | Stage II Uterine Corpus Cancer | Stage III Uterine Corpus Cancer | Stage IV Uterine Corpus Cancer | Endometrial AdenocarcinomaUnited States
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)Completed